Tower Research Capital (TRC)’s Artelo Biosciences ARTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.93K | Sell |
447
-204
| -31% | -$2.71K | ﹤0.01% | 4139 |
|
|
2025
Q1 | $3.42K | Buy |
651
+15
| +2% | +$79 | ﹤0.01% | 4415 |
|
|
2024
Q4 | $4.05K | Sell |
636
-228
| -26% | -$1.45K | ﹤0.01% | 4530 |
|
|
2024
Q3 | $5.81K | Sell |
864
-107
| -11% | -$719 | ﹤0.01% | 4216 |
|
|
2024
Q2 | $7.8K | Buy |
971
+160
| +20% | +$1.29K | ﹤0.01% | 4425 |
|
|
2024
Q1 | $7.21K | Buy |
811
+10
| +1% | +$89 | ﹤0.01% | 4242 |
|
|
2023
Q4 | $6.72K | Buy |
801
+444
| +124% | +$3.73K | ﹤0.01% | 4705 |
|
|
2023
Q3 | $3.13K | Sell |
357
-419
| -54% | -$3.67K | ﹤0.01% | 5049 |
|
|
2023
Q2 | $9.26K | Buy |
776
+88
| +13% | +$1.05K | ﹤0.01% | 4287 |
|
|
2023
Q1 | $10K | Buy |
688
+416
| +153% | +$6.05K | ﹤0.01% | 4323 |
|
|
2022
Q4 | $5K | Buy |
272
+62
| +30% | +$1.14K | ﹤0.01% | 4830 |
|
|
2022
Q3 | $4K | Buy |
210
+156
| +289% | +$2.97K | ﹤0.01% | 5223 |
|
|
2022
Q2 | $2K | Sell |
54
-165
| -75% | -$6.11K | ﹤0.01% | 5507 |
|
|
2022
Q1 | $9K | Buy |
219
+158
| +259% | +$6.49K | ﹤0.01% | 4430 |
|
|
2021
Q4 | $3K | Sell |
61
-49
| -45% | -$2.41K | ﹤0.01% | 5414 |
|
|
2021
Q3 | $8K | Buy |
110
+73
| +197% | +$5.31K | ﹤0.01% | 4517 |
|
|
2021
Q2 | $4K | Buy |
37
+23
| +164% | +$2.49K | ﹤0.01% | 4791 |
|
|
2021
Q1 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 4996 |
|
|
2020
Q3 | – | Sell |
-8
| Closed | -$1K | – | 4808 |
|
|
2020
Q2 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 4580 |
|
|
2019
Q4 | – | Sell |
-3
| Closed | -$1K | – | 3503 |
|
|
2019
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 3814 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3640 |
|